InvestorsHub Logo

DewDiligence

09/17/21 10:50 AM

#239592 RE: Preciouslife1 #239588

Whether or not Remdesivir works, much better COVID therapeutics are desperately needed. That’s today’s plug for ENTA :- )

jondoeuk

09/17/21 12:59 PM

#239595 RE: Preciouslife1 #239588

Participants had a median of 9 days of symptoms at the time of randomisation to therapy, with a range of 7 to 12 days. That is far too late. The key is giving it in the first few days and this will help prevent infected patients from getting sick enough to require hospitalisation.

DFRAI

09/20/21 8:44 PM

#239633 RE: Preciouslife1 #239588

Remdesivir showed no benefit and actually 54% of patients died in the Ebola study for which it was intended and extrapolated to Covid. So administering it to Covid patients caused patients to die from complications - about 31% due to side effects mainly liver failure etc
Adding steroids and antibiotics only complicated side effects and about 45% of Covid patients died in hospitals

This is the medical care offered to Covid patients - no wonder patients are dying. Trust the system.

Sad times and the guardians are asleep at the wheel or rather acting criminally by not disclosing the effects of the vaccines